Sekiguchi N, Rai S, Munakata W, Suzuki K, Handa H, Shibayama H, Endo T, Terui Y, Iwaki N, Fukuhara N, Tatetsu H, Iida S, Ishikawa T, Shiibashi R, Izutsu K.

A multicenter, open-label, phase II study of tirabrutinib (ONO/GS-4059) in patients with Waldenström’s macroglobulinemia.

Cancer Sci 111(9):3327-3337,2020. doi: 10.1111/cas.14561. Epub 2020 Jul 20.

https://pubmed.ncbi.nlm.nih.gov/32639651/